The global cyclin dependent kinase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cyclin-dependent kinases (CDKs) are protein kinases that are categorized by requiring a separate subunit, a cyclin. They provide domains essential for enzymatic activity and plays an important role in the control of cell division. Additionally, they modulate transcription in response to several extra- and intracellular cues. The major factor driving the growth of the market is the increasing prevalence of cancer across the globe.
To Request a Sample of our Report on Cyclin Dependent Kinase Market: https://www.omrglobal.com/request-sample/cyclin-dependent-kinase-market
According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Additionally, the most common cancers include breast cancer, lung and bronchus cancer, and leukemia, among others. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers include breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020. Hence, the rising prevalence of cancer is supporting the demand for cyclin dependent kinase to block uncontrolled cellular proliferation, which in turn, is driving the growth of the market.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Route of Administration
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Pfizer Inc., Eli Lilly and Company, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Cyclin Dependent Kinase Market is Available @ https://www.omrglobal.com/industry-reports/cyclin-dependent-kinase-market
Global Cyclin Dependent Kinase Market Report by Segment
By Type
- Specific inhibitors
- Non-Specific or Broad Range Inhibitors
- Multiple target inhibitors
- By Route of administration
- Nasal
- Oral
- Intravenous
- Intramuscular
By Application
- Breast cancer
- Lymphoma
- Multiple Myeloma
- Ovarian cancer
- Others
Global Cyclin Dependent Kinase Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
